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Absence Seizures as a Feature of Juvenile Myoclonic Epilepsy in
Rhodesian Ridgeback Dogs
F. Wielaender , F.M.K. James , M.A. Cortez, G. Kluger, J.N. Neßler, A. Tipold, H. Lohi, and
A. Fischer
Myoclonic epilepsy in Rhodesian Ridgeback (RR) dogs is characterized by myoclonic seizures occurring mainly during
relaxation periods, a juvenile age of onset and generalized tonic-clonic seizures in one-third of patients. An 8-month-old
female intact RR was presented for myoclonic seizures and staring episodes that both started at 10 weeks of age. Testing for
the DIRAS1 variant indicated a homozygous mutant genotype. Unsedated wireless video-electroencephalography (EEG) iden-
tiﬁed frequent, bilaterally synchronous, generalized 4 Hz spike-and-wave complexes (SWC) during the staring episodes in
addition to the characteristic myoclonic seizures with generalized 4–5 Hz SWC or 4–5 Hz slowing. Photic stimulation did not
evoke a photoparoxysmal response. Repeat video-EEG 2 months after initiation of levetiracetam treatment disclosed a >95%
decrease in frequency of myoclonic seizures, and absence seizures were no longer evident. Absence seizures represent another
seizure type in juvenile myoclonic epilepsy (JME) in RR dogs, which reinforces its parallels to JME in humans.
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A novel genetic myoclonic epilepsy in juvenileRhodesian Ridgeback (RR) dogs, characterized by
vigorous myoclonic seizures that occur mainly during
relaxation periods, recently has been described.1 More
than one-third of aﬀected dogs develop generalized
tonic-clonic seizures in the course of the disease, and
35% are reported to be photosensitive.1 The mean age
of onset is 6 months (range, 6 weeks–1.5 years).1 Wire-
less video-electroencephalography (EEG) in unsedated
dogs was used as a tool to investigate the spontaneous
and recurrent epileptic nature and to characterize the
EEG features of the electroclinical syndrome.1 Ambula-
tory video-EEG conﬁrmed the epileptic origin of the
myoclonic twitches.1 Typically, aﬀected dogs show gen-
eralized 4–5 Hz spike-and-wave complexes (SWC) and
polyspike-wave complexes (PSWC) with a fronto-central
maximum.1 Genetic analyses identiﬁed a fully penetrant
autosomal recessive 4-bp truncating deletion mutation
in the DIRAS1 gene, which is suggested to play a role
in acetylcholine release.1,2
Myoclonic epilepsy in RRs has important parallels to
juvenile myoclonic epilepsy (JME) in humans, including
juvenile onset, myoclonic seizures as the predominant
seizure type with propagation to generalized tonic-clo-
nic seizures, similar EEG characteristics and photo-
sensitivity.3–6 In humans with JME however, apart
from myoclonic seizures and generalized tonic-clonic
seizures (80–95% of patients), a third seizure type,
namely absence seizures (approximately 30% of
patients), is reported.7,8 In the following case report, we
describe the occurrence of absence seizures in a RR dog
diagnosed with JME, completing the triad of seizure
types observed in humans with JME.
An 8-month-old female intact RR was presented for
multiple episodes of unresponsiveness, staring into space
without any visible purposeful movement. Additionally,
the dog experienced myoclonic jerks that occurred
mainly at rest. Age of onset of both entities was
10 weeks with myoclonic seizures being observed a few
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days earlier than the staring episodes. At the beginning,
myoclonic jerks manifested as nodding movements of
the head, but became more vigorous in the course of
the disease. At time of presentation, myoclonic seizures
were said to resemble an electric shock such that the
dog would jump into the air. Photosensitivity was not
reported. Prior treatment with imepitoin (12.6 mg/kg
PO q12h) decreased the intensity but not the frequency
of the myoclonic seizures and did not inﬂuence the fre-
quent staring episodes. According to the owner, the
dog’s behavior was normal between episodes, and the
dog did not show learning diﬃculties or any develop-
mental delay.
Results of physical and neurologic examinations, as
well as CBC, serum biochemistry proﬁle, plasma ammo-
nia concentrations, and abdominal ultrasound examina-
tion were unremarkable. Testing for the DIRAS1
variant identiﬁed the homozygous mutant genotype
(c.564_567delAGAC). Unsedated wireless video-EEG
with synchronized video recording was performed using
an ambulatory EEG recordera in a quiet environment
in which the dog was encouraged to lie down, because
the episodes in question were reportedly more likely to
occur at rest. Fifteen subdermal stainless-steel needle
electrodes were used (F3, Fz, F4, F7, F8, C3, Cz, C4,
O1, Pz, O2, T3, T4, Ref, Neut). Electrodes were placed
as described previously and could be placed without
any sedation.1 Impedance was kept <10 kOhm. Time of
recording was approximately 2 hours. At the end of the
EEG study, photic stimulation was performed, utilizing
a lamp with circular reﬂector and a viewing distance of
30 cm. The following ﬂash frequencies (in Hz) were
used in this order: 1 – 6 – 11 – 18 – 7 – 12 – 16 – 4 –
25 – 10 – 17 – 9 – 14 – 3, employing a period of 10 sec-
onds of stimulation followed by a rest of 5 seconds per
ﬂash frequency.
Frequent episodes occurred, where the dog stared
into the space and did not respond to any stimulus pre-
sented by us. Video-EEG conﬁrmed the occurrence of
generalized 4 Hz SWC associated with the staring
events (Fig 1). During these episodes, the dog occasion-
ally would lower the neck and appear as if the dog were
about to buckle (Video S1; 14:12:30 hours). The dog’s
behavior was normal before (Video S2; 13:54:58 hours)
and after the staring events (Video S3; 14:13:11 hours).
The dog also showed several vigorous myoclonic sei-
zures (213 jerks in the ﬁrst hour of recording) that were
characterized by twitches of the face, cervical, and prox-
imal limb musculature or the trunk, accompanied by
generalized 4–5 Hz SWC with a central maximum
(Fig 2, Video S4; 14:13:52 hours) or 4–5 Hz slowing,
and sporadic single spikes. During photic stimulation,
some myoclonic seizures occurred, but seizure frequency
did not change and the myoclonic seizures were not
associated in time with the photic stimuli. Therefore,
the dog was not classiﬁed as photosensitive. A diagnosis
of JME in RRs with occurrence of myoclonic seizures
and absence seizures was made.
A 20-minute wireless video-EEG with subsequent
photic stimulation was performed on 5 healthy relatives
with known genotype (mother [heterozygous], 2 sisters
[both wild type], 2 brothers [1 wild type, 1 heterozy-
gous]), and 1 aﬀected littermate (male, homozygous for
the DIRAS1 variant, 1 hour of recording). Healthy con-
trols had normal EEG and no photosensitivity. The
aﬀected brother had myoclonic twitches that started at
9 weeks of age. Generalized tonic-clonic seizures or
absence seizures were not observed by the owner. The
EEG demonstrated myoclonic seizures associated with
polyspikes or PSWC, no absence seizures, and no pho-
toparoxysmal response upon photic stimulation.
Treatment with levetiracetam (24 mg/kg PO q8h) was
initiated, and imepitoin was tapered. Owners were asked
to keep a seizure diary. To ensure punctual drug admin-
istration, the owners used an automated dispensing
machine that was ﬁlled with the pills embedded in
treats. Owners reported a substantial decrease in seizure
frequency and intensity, from multiple violent myoclo-
nic jerks per day to 1 mild myoclonic twitch per week
and a complete cessation of absence seizures.
Fig 1. Absence seizure with generalized 4 Hz spike-and-wave complexes. Referential montage (G2 = Ref). Low pass ﬁlter: 70 Hz; high
pass ﬁlter: 0.53 Hz; gain: 150 lV/cm.
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Two months after treatment onset with levetiracetam,
a follow-up EEG was performed. One-hour unsedated
video-EEG disclosed only 6 mild and hardly visible
myoclonic seizures (97.2% decrease in seizure frequency
compared to the initial recording), and absence seizures
were no longer recorded.
Discussion
In human medicine, JME is a common type of idio-
pathic generalized epilepsy, accounting for 4.1% of all
epilepsies and 26.7% of idiopathic generalized
epilepsies.4 Juvenile myoclonic epilepsy usually begins
between 12 and 18 years of age, with a mean age of onset
of approximately 14 years.9 Myoclonic jerks usually
occur after awakening, are bilateral, arrhythmic, and
predominate on the upper limbs, making the patients
drop or throw objects.3 Most patients with JME con-
tinue to develop rare generalized tonic-clonic seizures,
which often are preceded by a cluster of myoclonic jerks,
and approximately 30% experience absence seizures.7,8
Photosensitivity is seen in another 30% of patients.10
Electroencephalography identiﬁes generalized and irregu-
lar SWC and PSWC with a fronto-central accentua-
tion.4,11 Complete seizure control is achieved in the
majority of patients, but relapse rate after antiepileptic
drug (AED) withdrawal may be up to 91%.12,13 Despite
a strong genetic background with positive family history
in at least 40% of patients and several genetic loci associ-
ated with this syndrome, no unique pathogenic mecha-
nism has yet been identiﬁed.9,14
Juvenile myoclonic epilepsy in humans and dogs
shares a wide range of similar characteristics such as
myoclonic seizures, generalized tonic-clonic seizures,
ictal and interictal EEG features, and photosensitivity.
The disease occurs in juvenile patients in both species,
but onset may be much earlier in a substantial portion
of dogs, with some being as young as 6 weeks of age.1
In the current case report, we describe the manifestation
of absence seizures in a RR dog suﬀering from JME,
highlighting another important parallel to JME in
humans.
The International League Against Epilepsy (ILAE)
deﬁnes absence seizures as “sudden cessation of activity
with a brief pause and staring, sometimes with eye ﬂut-
tering and head nodding or other automatic behaviors”
with an obligatory EEG pattern of generalized spike
waves.15 This deﬁnition holds true for the behavior and
EEG pattern observed in the dog described here.
Several theories have been advanced to explain the
pathophysiology of absence seizures.16 The initial
hypothesis suggests that generalized SWC are created
by a pacemaker in the brainstem and diencephalon
(centrencephalic theory), whereas the “thalamic clock
theory” assumes a pacemaker in the reticular thalamic
nucleus.16,17 The “corticoreticular theory”, proposing a
thalamocortical network for the generation of general-
ized seizures and SWC, has attracted much
attention.16,17 Although this concept postulates that the
SWC seen in absence seizures are a consequence of the
transformation of sleep spindles in the hyperexcitable
cortex, another study concluded that, although both
spike-wave discharges and sleep spindles arise from the
cortico-thalamo-cortical network, the initiation site of
the activity is diﬀerent with sleep spindles emerging
from the thalamus and spike-wave discharges from the
cortex (cortical focus theory).16,18,19
To our knowledge, only 1 other case report describes
absence seizures with myoclonic features in a dog.20 An
8-month-old Chihuahua was presented for staring epi-
sodes associated with head and nose twitching.20 Diag-
nostic evaluation (neurologic examination and blood
evaluation, magnetic resonance imaging [MRI]) was
unremarkable.20 Long-term video-EEG identiﬁed gener-
alized bilaterally synchronous 4 Hz SWC time-locked to
the clinical events.20 However, the prevalence of absence
seizures in dogs may be highly underestimated. In 1
study, owners perceived a generalized tonic-clonic seizure
to be more harmful than a focal seizure and were less
likely to report a focal seizure to their veterinarian.21
Fig 2. Myoclonic seizure with generalized 4–5 Hz spike-and-wave complexes. Referential montage (G2 = Ref). Low pass ﬁlter: 70 Hz;
high pass ﬁlter: 0.53 Hz; gain: 150 lV/cm.
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Similarly, owners and veterinarians might underestimate
the impact of absence seizures or not even identify those
episodes as being epileptic. Some patients with absence
seizures may go on to develop generalized tonic-clonic
seizures. Therefore, the clinician should speciﬁcally ask
about the occurrence of absence seizures and educate the
owner about the semiology of this seizure type. More-
over, a deﬁnitive diagnosis of absence seizures requires
conﬁrmation by EEG. In the majority of studies in which
EEG was used as a diagnostic tool, dogs were sedated or
even anesthetized.22–27 This technique makes the diagno-
sis of absence seizures challenging, because level of alert-
ness or consciousness, a key factor for the diagnosis of
absence seizures, cannot be assessed. Consequently, EEG
should be performed in unsedated dogs to enable the
diagnosis of absence seizures.28
The dog in our study exhibited typical absence sei-
zures characterized by impaired consciousness in associ-
ation with generalized SWC with a frequency of 4 Hz.
In human medicine, absence seizures are considered as
transient impairment of consciousness time-locked to
generalized 3 Hz spike-wave discharges.29 In the current
understanding, however, typical absence seizures that
occur in association with idiopathic generalized epilep-
sies are characterized by generalized spike- or poly-
spike-wave discharges with a frequency of >2.5 Hz
(mainly 3–4.5 Hz) similar to those observed in the dog
of our study.19,30 In contrast, atypical absence seizures
are observed in human patients in the context of cogni-
tive-related conditions and symptomatic epilepsies (eg,
Lennox-Gastaut syndrome) and are characterized by
lower frequencies.19,30 Furthermore, the frequency of
spike-wave discharges in absence seizures varies with
diﬀerent types of epilepsy syndromes in humans.29 In
JME, absence seizures with 3–4 Hz spike-wave dis-
charges are described similar to the 4 Hz SWC in the
dog described here and the Chihuahua with absence
seizures with myoclonic features.20,29
Short elimination half-life time (90–120 minutes) pre-
vents the use of valproic acid in dogs, which is the ﬁrst
choice AED in humans with JME, reaching eﬀective-
ness of 85–90%.9 Therefore, other AEDs with an
appropriate pharmacokinetic proﬁle are used in dogs.
Levetiracetam is another eﬀective drug to treat JME in
humans and is superior to phenobarbital for the treat-
ment of myoclonic seizures in cats with feline audio-
genic reﬂex seizures.31,32 For the RR in this report,
treatment with imepitoin resulted only in mild reduction
in intensity of myoclonic seizures, but frequency of
myoclonic and absence seizures did not change. In con-
trast, much improvement of intensity and frequency of
myoclonic seizures and complete cessation of absence
seizures were achieved by levetiracetam treatment.
Therefore, levetiracetam may be considered for the
treatment of myoclonic seizures as well as absence sei-
zures in veterinary medicine. However, more studies are
warranted to conﬁrm our observations.
Our study had several limitations. Because there is
currently only 1 case with proven absence seizures in
a RR with JME, occurrence of this seizure type could
just be a coincidental ﬁnding. However, humans with
idiopathic generalized epilepsies can present with vari-
ous generalized seizure types such as generalized tonic-
clonic, tonic, clonic, atonic, myoclonic, or absence
seizures.33 Therefore, absence seizures indeed can be a
feature of JME in RRs. Moreover, several owners of
RRs with JME that were presented to our clinics
reported that their dogs were experiencing staring epi-
sodes. Although conﬁrmation by video-EEG was not
attempted in those dogs, these observations suggest that
absence seizures might be a more common seizure type
in RRs with JME than expected. In the present case,
absence seizures were conﬁrmed by EEG at the age of
8 months, whereas for the controls (1 aﬀected and 4
healthy littermates), EEG was performed at the age of
10 months. Therefore, absence seizures could have been
an age-related phenomenon that vanished over time.
However, in contrast to the current case, owners of
controls never observed staring episodes in their dogs.
Brain imaging was not performed in the RR of this case
report. However, the neurologic examination was nor-
mal and the dog tested positive for the DIRAS1 variant.
In the previous study, RRs with JME had normal MRI
ﬁndings.1 Furthermore, the RR of this report had an
EEG pattern of generalized epileptic discharges and no
focal discharges. Taking these points together, we con-
sidered structural brain disease very unlikely.
The current case report describes the occurrence of
absence seizures in a RR diagnosed with JME. Our
ﬁndings expand the spectrum of JME to include a third
seizure type and highlight the potential to use this dog
breed as a large animal translational model for the
investigation of pathophysiologic, therapeutic, and
genetic aspects of JME in humans. Furthermore, the
usefulness of unsedated wireless video-EEG for the
diagnosis of seizure types and electroclinical syndromes
with staring episodes is emphasized.
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Video S1. Absence seizure with generalized 4 Hz
SWC at 14:12:34 hours. The RR is nonresponsive to
stimuli, slightly swaying and holds the neck in a ﬂexed
position. Referential montage (G2 = Ref). Low pass ﬁl-
ter: 70 Hz; high pass ﬁlter: 0.53 Hz; gain: 150 lV/cm.
Video S2. Dog of video S1 showing normal behavior
between a myoclonic seizure and an absence seizure at
13:54:58 hours. EEG is superimposed by muscle and
movement artifact. Referential montage (G2 = Ref).
Low pass ﬁlter: 70 Hz; high pass ﬁlter: 0.53 Hz; gain:
150 lV/cm.
Video S3. Dog of video S1 showing normal behavior
after an absence seizure at 14:13:10 hours. EEG is
superimposed by marked muscle and movement arti-
fact. Referential montage (G2 = Ref). Low pass ﬁlter:
70 Hz; high pass ﬁlter: 0.53 Hz; gain: 150 lV/cm.
Video S4. Dog of video S1 at 14:13:53 hours. Myo-
clonic seizure with generalized 4–5 Hz SWC in associa-
tion with some muscle artifact during myoclonic
twitches. Referential montage (G2 = Ref). Low pass ﬁl-
ter: 70 Hz; high pass ﬁlter: 0.53 Hz; gain: 150 lV/cm.
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